Durham, NC – According to filings with the U.S. Securities and Exchange Commission, Xilis is raising $70,000,006.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Xiling Shen played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Xilis
Developing next generation technologies for precision medicine and drug discovery.

To learn more about Xilis, visit http://www.xilis.net/

Contact:
Xiling Shen, Chief Executive Officer
607-397-4121
xiling.shen@xilis.net
https://www.linkedin.com/in/xiling-shen-75816b2/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved